Ferrous sulfate contraindications
Pro Research Analysisby 
Searched over 200M research papers
Contraindications of Ferrous Sulfate: A Comprehensive Overview
Gastrointestinal Side Effects of Ferrous Sulfate
Ferrous sulfate, a common treatment for iron deficiency anemia (IDA), is often associated with significant gastrointestinal (GI) side effects. A systematic review and meta-analysis of 43 trials involving 6831 adult participants revealed that ferrous sulfate significantly increases the risk of GI side effects compared to placebo and intravenous (IV) iron. The odds ratio (OR) for GI side effects was 2.32 when compared to placebo and 3.05 when compared to IV iron . These side effects include nausea, heartburn, abdominal pain, diarrhea, and constipation, which can lead to poor compliance with the treatment .
Comparison with Alternative Iron Supplements
Studies comparing ferrous sulfate with other iron supplements have shown varying results in terms of efficacy and side effects. For instance, ferrous bisglycinate chelate has been found to have similar efficacy but lower GI toxicity compared to ferrous sulfate in cancer patients with mild IDA . Similarly, iron-enriched Aspergillus oryzae (ULT) showed better compliance and fewer GI side effects than ferrous sulfate while maintaining normal iron status in women . Another study comparing ferric citrate with ferrous sulfate in patients with chronic kidney disease (CKD) found that ferric citrate resulted in a greater increase in transferrin saturation (TSAT) and ferritin levels without a significant difference in adverse events .
Special Populations and Considerations
Children with Autism Spectrum Disorders
In children with autism spectrum disorders (ASD) and low normal ferritin levels, a randomized placebo-controlled trial found that ferrous sulfate improved iron status but did not significantly improve primary measures of insomnia. The treatment was well tolerated, with no serious adverse events reported .
Non-Anemic Healthy Adults
A study on non-anemic healthy adults found that ferrous sulfate supplementation did not increase the risks of malarial infectivity, pathogenic bacterial proliferation, or other adverse effects. This suggests that ferrous sulfate is well tolerated in this population .
Infants with Iron-Deficiency Anemia
In infants with iron-deficiency anemia, a study comparing single versus three-times-daily doses of ferrous sulfate found similar rates of successful treatment of anemia with minimal side effects. This indicates that a single daily dose may improve adherence without compromising efficacy .
Conclusion
Ferrous sulfate is an effective treatment for iron deficiency anemia but is associated with significant gastrointestinal side effects, which can affect patient compliance. Alternative iron supplements such as ferrous bisglycinate chelate, iron-enriched Aspergillus oryzae, and ferric citrate may offer similar efficacy with fewer side effects. Special populations, including children with ASD and non-anemic healthy adults, generally tolerate ferrous sulfate well, but alternative dosing regimens may improve adherence in infants. Overall, the choice of iron supplement should consider both efficacy and the potential for adverse effects to optimize patient outcomes.
Sources and full results
Most relevant research papers on this topic